Illumina Lays off More Than 300 Employees
The company has reduced its head count by approximately 5 percent so far this year and has laid off approximately 1,000 employees since late 2022.
NIH Funding Cut by 40 Percent in Trump Admin's FY2026 Budget Proposal
The proposal also details the administration's plan to eliminate four NIH institutes or centers while combining the remaining 23 into a total of eight.
ESCMID Presenters Make Case for Clinical Implementation of Metagenomics for Infectious Disease Dx
Premium
In a session at the conference, multiple researchers presented data on their implementation of metagenomic sequencing for diagnostic use cases.
GeneDx to Offer Genome Interpretation as a Standalone Service Following Fabric Genomics Acquisition
Premium
GeneDx, which has been running a centralized lab, hopes to provide the new service to hospitals in the US and abroad that are already sequencing genomes in-house.
Cepheid, Oxford Nanopore to Broaden Use Case for Nanopore Sequencing in Infectious Disease Testing
Premium
The firms are developing a workflow that will include Cepheid's sample and library preparation, nanopore sequencing, and automated data analysis.
RARE-seq, a protocol optimized by veteran liquid biopsy researchers Max Diehn and Ash Alizadeh, could soon be commercialized in a spinout.
Diagnostics for the Real World Prepares to Launch Retooled Rapid Point-of-Care Testing Platform
Premium
The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease panels at the ESCMID global congress in Vienna.